
Emcure Pharmaceuticals Ltd. share price
NSE: EMCURE · Healthcare
₹2,338.80 -0.97%
Closing price data, updated 17 Nov 2026. 52-week range: -2.4% from high, +78.2% above low.
Price₹2,338.80
Market cap₹44,370 Cr
P/E40.6
P/B8.30
ROE19.7%
ROCE24.8%
Debt / equity0.31
Dividend yield0.00%
EPS₹57.64
Book value₹281.69
Operating margin15.1%
Dipscan score56 / 100
Share: WhatsAppX / TwitterTelegram
Emcure Pharmaceuticals Ltd. shareholding pattern
As of Sep 2026: Promoters 77.82%, FIIs 4.94%, DIIs 8.49%, Government 0.00%, Public 6.34%, Others 2.40%.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Promoters | 77.82% | 77.83% | 77.87% | 77.87% | 77.88% | 77.91% |
| FIIs | 4.94% | 4.88% | 3.35% | 3.59% | 3.29% | 2.86% |
| DIIs | 8.49% | 8.46% | 6.10% | 6.10% | 4.37% | 2.84% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 6.34% | 6.45% | 6.46% | 6.46% | 6.24% | 5.95% |
| Others | 2.40% | 2.38% | 6.22% | 5.98% | 8.22% | 10.44% |
| No. of Shareholders | 129,328 | 124,991 | 122,189 | 118,863 | 126,169 | 133,549 |
As filed by the company with the exchanges.
Returns
| 1 day | 1 week | 1 month | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| -0.97% | +5.69% | +25.32% | +16.38% | +39.57% | +70.75% |
Growth
| Sales growth, 3 years | +15.4% |
| Sales growth, 5 years | – |
| Profit growth, 3 years | +20.2% |
| Profit growth, 5 years | – |
| Latest quarter sales vs last year | +24.3% |
| Latest quarter profit vs last year | +33.7% |
Strengths and weaknesses
Weaknesses
- Stock is trading at 8.30 times its book value
Peers in Healthcare
| Company | Price | Market cap | P/E | ROE | 1 year |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | ₹1,867.50 | ₹4,48,076 Cr | 40.9 | 14.7% | +8.8% |
| Divi's Laboratories Ltd. | ₹11,080.00 | ₹2,94,139 Cr | 87.5 | 16.2% | +69.4% |
| Torrent Pharmaceuticals Ltd. | ₹4,691.20 | ₹1,78,438 Cr | 84.0 | 27.1% | +22.6% |
| Apollo Hospitals Enterprise Lt | ₹8,771.00 | ₹1,26,114 Cr | 56.2 | 21.9% | +16.9% |
| Laurus Labs Ltd. | ₹2,220.00 | ₹1,19,949 Cr | 89.5 | 18.2% | +125.2% |
| Zydus Lifesciences Ltd. | ₹1,192.00 | ₹1,18,902 Cr | 28.4 | 19.7% | +27.0% |
| Dr. Reddy's Laboratories Ltd. | ₹1,377.90 | ₹1,14,778 Cr | 41.0 | 12.1% | +13.7% |
| Cipla Ltd. | ₹1,394.50 | ₹1,12,658 Cr | 38.9 | 11.8% | -8.0% |
Frequently asked questions
What is the share price of Emcure Pharmaceuticals Ltd.?
Emcure Pharmaceuticals Ltd. (EMCURE) last closed at ₹2,338.80 (-0.97% on the day).
What is the market cap of Emcure Pharmaceuticals Ltd.?
About ₹44,370 Cr.
What is the P/E ratio of Emcure Pharmaceuticals Ltd.?
The price-to-earnings ratio is 40.6, and return on equity is 19.7%.
Figures are calculated from company results and exchange prices and are for information only.